Breaking News Instant updates and real-time market news.

MANU

Manchester United

$20.55

0.8 (4.05%)

, BBT

BB&T

$55.49

0.49 (0.89%)

04:55
05/16/18
05/16
04:55
05/16/18
04:55

Barclays to hold a conference

Americas Select Franchise Conference will be held in London, England on May 15-16.

MANU

Manchester United

$20.55

0.8 (4.05%)

BBT

BB&T

$55.49

0.49 (0.89%)

MCO

Moody's

$170.78

-1.18 (-0.69%)

STI

SunTrust

$69.29

0.37 (0.54%)

CFG

Citizens Financial

$42.71

0.37 (0.87%)

TRU

TransUnion

$69.06

-0.07 (-0.10%)

INFO

IHS Markit

$51.71

-0.22 (-0.42%)

MTZ

MasTec

$48.85

-0.1 (-0.20%)

ZION

Zions Bancorp

$57.83

0.23 (0.40%)

FDS

FactSet

$196.77

0.46 (0.23%)

SLM

Sallie Mae

$11.55

0.02 (0.17%)

AVY

Avery Dennison

$106.31

-1.855 (-1.72%)

NYCB

New York Community Bancorp

$11.94

0.11 (0.93%)

NLSN

Nielsen

$30.73

0.215 (0.70%)

DFS

Discover

$76.31

0.85 (1.13%)

  • 16

    May

  • 16

    May

  • 17

    May

  • 17

    May

  • 22

    May

  • 30

    May

  • 12

    Jun

  • 20

    Jul

  • 19

    Oct

MANU Manchester United
$20.55

0.8 (4.05%)

BBT BB&T
$55.49

0.49 (0.89%)

03/27/18
RILY
03/27/18
UPGRADE
Target $59
RILY
Buy
BB&T upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Steve Moss upgraded BB&T to Buy and raised his price target for the shares to $59 from $55. Wells Fargo this morning also upgraded the shares to Buy. The analyst says the recent pullback in the shares, coupled with the bank's "solid" outlook, create a buying opportunity.
04/23/18
HDLY
04/23/18
UPGRADE
HDLY
Buy
BB&T upgraded to Buy from Neutral at Hilliard Lyons
03/27/18
03/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BB&T (BBT) upgraded to Buy from Neutral at B. Riley FBR and to Outperform from Market Perform at Wells Fargo. 2. Aratana Therapeutics (PETX) upgraded to Buy from Hold at Stifel with analyst Jonathan Block saying the early traction for Entyce, which was launched October 2017, has increased his conviction that the drug will act as the main revenue driver for Aratana in coming years. 3. Prologis (PLD) upgraded to Overweight from Neutral at JPMorgan with analyst Michael Mueller saying he is shuffling his ratings in the REIT space following GGP's (GGP) takeout by Brookfield Property Partners (BPY). 4. Brookfield Property (BPY) upgraded to Buy from Hold at Canaccord. 5. Roku (ROKU) upgraded to Neutral from Sell at Citi with analyst Mark May citing valuation for the upgrade following the stock's recent underperformance, but admits the upcoming lock-up expiration could serve as a negative catalyst. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/18
EDJN
04/11/18
UPGRADE
EDJN
Buy
BB&T upgraded to Buy from Hold at Edward Jones
MCO Moody's
$170.78

-1.18 (-0.69%)

04/25/18
NOMU
04/25/18
NO CHANGE
Target $190
NOMU
Buy
Moody's price target raised to $190 from $180 at Nomura Instinet
Nomura Instinet analyst Dan Dolev raised his price target for Moody's to $190 saying his revenue empirical study of global debt issuance versus the company's ratings organic growth points to potential 3%-4% upside to consensus estimates. The analyst reiterates a Buy rating on the shares.
02/12/18
WELS
02/12/18
NO CHANGE
Target $160
WELS
Market Perform
Moody's price target raised to $160 from $148 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for Moody's to $160 from $148 after the company reported Q4 revenue and EPS ahead of expectations, with upside driven primarily by strong issuance across all 4 divisions. The analyst reiterates a Market Perform rating on the shares.
02/12/18
FBCO
02/12/18
NO CHANGE
Target $187
FBCO
Neutral
Moody's price target raised to $187 from $161 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for Moody's to $187 from $161 after a "strong" update as expected, with margins looking a bit conservative. The analyst reiterates a Neutral rating on the shares.
02/14/18
ARGS
02/14/18
NO CHANGE
Target $190
ARGS
Buy
Moody's price target raised to $190 from $165 at Argus
Argus analyst John Eade raised his price target on Moody's to $190 and kept his Buy rating after a Q4 earnings beat, with results benefiting from the recent acquisition of Bureau van Dijk. The analyst is positive on the company's position to benefit from the "secular trends of global GDP growth and debt market disintermediation", along with opportunities to develop new products, raise margins, and grow through targeted acquisitions. Eade believes the valuation on Moody's is attractive relative to peers, with expected FY18 PE of 20.6-times vs. group range of 18-29-times.
STI SunTrust
$69.29

0.37 (0.54%)

04/23/18
SPHN
04/23/18
DOWNGRADE
SPHN
Equal Weight
Stephens downgrades SunTrust to Equal Weight on valuation
Stephens analyst Terry McEvoy downgraded SunTrust Banks to Equal Weight from Overweight without a price target. Deutsche Bank last night upgraded SunTrust to Buy from Hold. Following the company's Q1 results, McEvoy views the shares as fairly valued. SunTrust's returns will continue to improve, but at a more gradual pace, as the company nears its 60% efficiency target later this year, the analyst tells investors in a research note. Further, he believes the potential data theft by an ex-employee poses an additional risk.
01/08/18
MSCO
01/08/18
UPGRADE
Target $71
MSCO
Overweight
SunTrust upgraded to Overweight on mobile banking adoption at Morgan Stanley
As previously reported, Morgan Stanley analyst Betsy Graseck upgraded SunTrust to Overweight from Equal Weight, calling it the biggest beneficiary of rising mobile banking adoption among larger banks. Consumers are increasingly comfortable banking from their smartphones and by 2022 mobile apps will be the battleground for banks, Graseck tells investors. SunTrust, which has a strong mobile banking app with a higher rating and more features than peers, could reduce its branch count by 13% over the next five years as it leverages the mobile trend, contends Graseck, who raised her 2019 EPS estimates by a median 2% across the big banks and increased her price target on SunTrust shares to $71 from $68.
04/23/18
SPHN
04/23/18
DOWNGRADE
SPHN
Equal Weight
SunTrust downgraded to Equal Weight from Overweight at Stephens
02/14/18
OPCO
02/14/18
NO CHANGE
OPCO
Oppenheimer dropping coverage of SunTrust
Oppenheimer is discontinuing equity research coverage of SunTrust due to a realignment in analyst coverage.
CFG Citizens Financial
$42.71

0.37 (0.87%)

04/23/18
BMOC
04/23/18
NO CHANGE
Target $52
BMOC
Outperform
Citizens Financial price target lowered to $52 from $56 at BMO Capital
BMO Capital analyst Lana Chan lowered her price target on Citizens Financial to $52, saying that despite the Q1 earnings beat, the underlying trends were mixed with weak loan growth and weak fees along with a lower loan loss provision and better net interest margins. Chan keeps her Outperform rating on Citizens Financial, maintaining her positive outlook toward improvement in "below-peer profitability metrics through balance sheet optimization, improved fee income productivity, and higher capital returns".
04/03/18
DBAB
04/03/18
UPGRADE
DBAB
Buy
Citizens Financial upgraded to Buy from Hold at Deutsche Bank
04/04/18
DBAB
04/04/18
UPGRADE
Target $50
DBAB
Buy
Citizens Financial upgraded to Buy with $50 target at Deutsche Bank
Deutsche Bank analyst Matthew O'Connor last night upgraded Citizens Financial Group (CFG) to Buy with an unchanged price target of $50. The analyst upgrades the stock following the recent pullback ahead of the Q1 earnings season. U.S. Bancorp (USB) remains his top pick among U.S. Banks.
04/23/18
SDLR
04/23/18
UPGRADE
SDLR
Buy
Citizens Financial upgraded to Buy from Hold at Sandler O'Neill
TRU TransUnion
$69.06

-0.07 (-0.10%)

04/23/18
RHCO
04/23/18
NO CHANGE
Target $78
RHCO
Buy
TransUnion price target raised to $78 from $64 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on TransUnion to $78 from $64, including the company's Callcredit UK acquisition expected to close in Q3 into his model. The analyst adds that he is impressed with the company's "strong USIS momentum" driven by newer solutions such as Trended Data in emerging verticals such as Healthcare. Jeffrey anticipates "ongoing momentum" for TransUnion, keeping his Buy rating on the stock.
04/23/18
BARD
04/23/18
NO CHANGE
Target $74
BARD
Outperform
TransUnion price target raised to $74 from $65 at Baird
Baird analyst Jeffrey Meuler raised his price target on TransUnion to $74 from $65 citing better than expected Q1 results. The analyst noted its increased guidance, how well-run the company is, and his confidence in the its ability to maintain its strong, broad-based business. Meuler reiterated his Outperform rating on TransUnion shares.
04/23/18
WELS
04/23/18
NO CHANGE
Target $65
WELS
Market Perform
TransUnion price target raised to $65 from $56 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for TransUnion to $65 from $56 after the company delivered Q1 results ahead of expectations, raised 2018 guidance, and announced the $1.4B acquisition of Callcredit. The analyst reiterates a Market Perform rating on the shares.
04/23/18
LEHM
04/23/18
NO CHANGE
Target $75
LEHM
Overweight
TransUnion price target raised to $75 from $65 at Barclays
Barclays analyst Manav Patnaik raised his price target for TransUnion to $75 following the company's better than expected Q1 results and Callcredit UK acquisition. Buying on the few remaining scale credit bureaus available is a "very sensible" move, Patnaik tells investors in a research note. The analyst keeps an Overweight rating on TransUnion shares.
INFO IHS Markit
$51.71

-0.22 (-0.42%)

02/02/18
WBLR
02/02/18
UPGRADE
WBLR
Outperform
IHS Markit upgraded to Outperform from Market Perform at William Blair
William Blair analyst Timothy McHugh last night upgraded IHS Markit to Outperform from Market Perform after assuming coverage from Brandon Dobell. The analyst sees upside to the company's guidance from favorable currency exchange rates. He believes IHS Markit will continue to exceed revenue projections.
03/28/18
PIPR
03/28/18
NO CHANGE
Target $57
PIPR
Overweight
IHS Markit price target raised to $57 from $54 at Piper Jaffray
Piper Jaffray analyst Peter Appert raised his price target for IHS Markit to $57 saying he sees "multiple upside catalysts" for the shares over the next 12-18 months. These include accelerating organic revenue growth, margin upside and leverage from improving free cash flow, Appert tells investors in a research note. The analyst says these catalysts were evident in the company's Q1 results. He reiterates an Overweight rating on IHS Markit.
03/28/18
RBCM
03/28/18
NO CHANGE
Target $57
RBCM
Outperform
IHS Markit price target raised to $57 at RBC Capital on 'strong' Q1 results
RBC Capital analyst Gary Bisbee raised his price target on IHS Markit to $57 from $55 and kept his Outperform rating, saying Q1 results saw a "broad-based revenue and margin outperformance". While the outlook for FY18 was maintained, the analyst contends that the guidance is actually "conservative" based on the management's positive Q1 commentary and maintains his view on IHS Markit stock as one of his "best ideas" combining improving revenue, strong margins and cash flow, as well as a "meaningful" valuation discount.
05/15/18
BMOC
05/15/18
NO CHANGE
Target $57
BMOC
Outperform
IHS Markit price target raised to $57 from $53 at BMO Capital
BMO Capital analyst Jeffrey Silber raised his price target on IHS Markit to $57, saying he is increasingly more confident that the company's mid-single-digit organic revenue growth will yield further margin expansion. Silber adds that the stock trades at a discount to its peers on most metrics, and the trend of continued organic growth may lead to multiple expansion given the visibility around its growth rate.
MTZ MasTec
$48.85

-0.1 (-0.20%)

03/01/18
CHLM
03/01/18
NO CHANGE
Target $69
CHLM
Buy
MasTec price target raised to $69 from $64 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for MasTec to $69 from $64 following the company's better than expected results and 2018 guidance. The analyst reiterates a Buy rating on the shares.
03/23/18
ADAM
03/23/18
NO CHANGE
Target $65
ADAM
Buy
MasTec named 'top mid-cap idea' at Canaccord
Canaccord analyst Bobby Burleson reiterated a Buy rating and $65 price target on MasTec, calling the stock his top mid-cap idea. In a research note to investors, Burleson said he has "high conviction" in MasTec's ability to deliver upside to estimates, adding that backlog momentum is "healthy" across multiple segments, and believes his assumptions for margins for Oil & Gas and revenues for Communications may prove conservative. The analyst believes demand remains "robust" and MasTec is in a good position to capture additional large scale work going forward, despite pipeline visibility that has been clouded by a "reluctance of owners to publicize future potential projects."
03/22/18
DBAB
03/22/18
UPGRADE
Target $48
DBAB
Buy
Deutsche Bank sees strong sales growth for MasTec, upgrades to Buy
Deutsche Bank analyst Nishu Sood upgraded MasTec (MTZ) to Buy and raised his price target for the shares to $48 from $43. The analyst's analysis indicates the company "should be well-placed to handle" rising costs for building products. Further, he thinks MasTec's sales growth should be strong in 2018 due to good remodeling trends and management's focus on driving organic sales growth. Sood coupled the upgrade with a downgrade of Jeld-Wen (JELD) to Hold.
03/22/18
SBSH
03/22/18
NO CHANGE
SBSH
Buy
MasTec recent pullback a buying opportunity, says Citi
Citi analyst Andrew Kaplowitz recommends using the recent pullback in shares of MasTec as a buying opportunity. In a research note titled "Growth at a Discount: Buy the Dip," Kaplowitz says visibility into Communications-related growth is better than it has been for MasTec since he's been covering the stock. In addition, he sees "no fall-off in Oil & Gas." The analyst keeps a Buy rating on the shares.
ZION Zions Bancorp
$57.83

0.23 (0.40%)

03/15/18
RAJA
03/15/18
UPGRADE
Target $61
RAJA
Outperform
Zions Bancorp upgraded to Outperform on valuation, growth at Raymond James
As previously reported, Raymond James upgraded Zions Bancorp to Outperform from Market Perform and established a $61 price target. Analyst David Long came away from recent management meetings with a better appreciation of risk reduction efforts, profitability improvements, increasing capital return levels, and positive operating leverage. Long believes shares are undervalued given earnings growth and improving profitability metrics.
03/22/18
UBSW
03/22/18
INITIATION
Target $67
UBSW
Buy
Zions Bancorp initiated with a Buy at UBS
UBS analyst Brock Vandervliet started Zions Bancorp with a Buy rating and $67 price target. The analyst rolled out coverage last night on the Mid-Cap Banks. He sees performance differentiation "playing out more starkly" than investors may expect with "increasingly advantaged and disadvantaged participants."
03/21/18
UBSW
03/21/18
INITIATION
UBSW
Buy
Zions Bancorp initiated with a Buy at UBS
05/14/18
WEDB
05/14/18
INITIATION
WEDB
Neutral
Zions Bancorp initiated with a Neutral at Wedbush
FDS FactSet
$196.77

0.46 (0.23%)

12/20/17
WELS
12/20/17
NO CHANGE
Target $185
WELS
Market Perform
FactSet price target raised to $185 from $175 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for FactSet to $185 from $175 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
03/15/18
DADA
03/15/18
NO CHANGE
Target $185
DADA
Neutral
FactSet price target raised to $185 from $174 at DA Davidson
DA Davidson analyst Peter Heckmann raised his price target on FactSet to $185 ahead of the company's Q2 earnings at the end of this month, citing expectations of lower effective tax rates leading to the management raising their FY18 guidance. Heckman keeps his Neutral rating, adding that while Factset has a strong track record, its current valuation is extended, and the market may become concerned with a challenging primary end market.
03/28/18
CANT
03/28/18
NO CHANGE
Target $203
CANT
Overweight
FactSet price target raised to $203 from $187 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for FactSet Research Systems to $203 following the company's Q2 results but keeps a Neutral rating on the name. Management continues to expect some margin improvement long term, but the timing will likely be pushed out from original expectations, Foresi tells investors in a post-earnings research note.
01/31/18
DADA
01/31/18
NO CHANGE
Target $174
DADA
Neutral
Thomson Reuters-Blackstone F&R talks are negative for FactSet, says DA Davidson at DA Davidson
DA Davidson analyst Peter Heckmann says that yesterday's disclosure of advanced talks between Blackstone (BX) and Thomson Reuters (TRI) about the sale of the latter's Financial & Risk - F&R - operations is a negative for Factset (FDS). The analyst believes that most of the market share wins for Factset have come from Reuters over the past two decades, and Blackstone's ability to better focus investments in the financial data business may make competitive wins for difficult. Heckmann keeps his Neutral rating and $174 price target, adding "FactSet's shares will be challenged to outperform the peer group over the next year".
SLM Sallie Mae
$11.55

0.02 (0.17%)

04/04/18
WELS
04/04/18
INITIATION
Target $13.5
WELS
Outperform
Sallie Mae initiated with an Outperform at Wells Fargo
Wells Fargo analyst Michael Kaye started Sallie Mae with an Outperform rating and $13.50 price target. The analyst views the valuation as attractive with the shares trading at 9.5 times his 2019 earnings estimate. This is a "significant" discount to the 20%-plus estimated earnings growth rate from 2017 to 2020, Kaye tells investors in a research note.
01/08/18
OPCO
01/08/18
INITIATION
Target $17
OPCO
Outperform
Sallie Mae initiated with an Outperform at Oppenheimer
Oppenheimer analyst Ben Chittenden started Sallie Mae with an Outperform rating and $17 price target.
01/08/18
OPCO
01/08/18
INITIATION
OPCO
Perform
Navient initiated with a Perform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Navient (NAVI) with a Perform rating. Chittenden says the bulk of the company revenue still comes from its legacy loan book and private student loan portfolio, and both of those segments are under pressure. The analyst adds that 2019 could mark a key turning point, when Navient's non-compete agreement with Sallie Mae (SLM) expires, allowing it to originate private student loans again.
01/08/18
OPCO
01/08/18
INITIATION
Target $17
OPCO
Outperform
Sallie Mae initiated with an Outperform at Oppenheimer
As reported earlier, Oppenheimer analyst Ben Chittenden initiated Sallie Mae with an Outperform rating and a price target of $17, citing a "secular mix shift away from Federal funding of educational tuition and toward private lenders" where the company has a leading market share. The analyst says Sallie Mae will continue to benefit from better efficiency ratio, estimating mid-30s % versus "40% range" currently.
AVY Avery Dennison
$106.31

-1.855 (-1.72%)

04/26/18
JPMS
04/26/18
UPGRADE
Target $107
JPMS
Neutral
Avery Dennison upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Avery Dennison to Neutral with a price target of $107. The analyst sees a more fair valuation following the company's Q1 results.
03/27/18
BMOC
03/27/18
INITIATION
Target $120
BMOC
Market Perform
Avery Dennison initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Avery Dennison with a Market Perform rating and $120 price target.
03/16/18
JPMS
03/16/18
DOWNGRADE
Target $107
JPMS
Underweight
Avery Dennison downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Avery Dennison to Underweight and cut his price target for the shares to $107 from $113. The shares have moved higher without any change in underlying business fundamentals, Zekauskas tells investors in a research note. He sees little capital appreciation potential for the shares in fiscal 2018.
05/02/18
LOOP
05/02/18
NO CHANGE
Target $111
LOOP
Hold
Avery Dennison price target lowered to $111 from $117 at Loop Capital
Loop Capital analyst Chris Kapsch lowered his price target on Avery Dennison to $111, saying that while the company beat on Q1 earnings and raised its guidance, the "quality of its earnings progression" was less favorable. The analyst says Avery Dennison is "stepping up its investment in restructuring to drive further margin improvement", which suggests there may be "deceleration across the broader pressure sensitive adhesives market globally". Kapsch sees the risk-reward as "generally balanced" while its strong free cash flows and "buyback propensity" support the valuation on the stock, keeping his Hold rating.
NYCB New York Community Bancorp
$11.94

0.11 (0.93%)

02/12/18
RILY
02/12/18
UPGRADE
Target $13
RILY
Neutral
New York Community Bancorp upgraded to Neutral from Sell at B. Riley FBR
B. Riley FBR analyst Stephen Moss upgraded New York Community Bancorp to Neutral and raised his price target for the shares to $13 from $12. The analyst says the company's "substantial" expense reduction will help offset its net interest margin pressure.
01/10/18
BOFA
01/10/18
UPGRADE
Target $15
BOFA
Buy
New York Community Bancorp upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Ebrahim Poonawala upgraded New York Community Bancorp to Buy with a $15 price target. The analyst believes cash redeployment will support earnings growth, expense leverage provides earnings upside, potential SIFI regulation changes could unlock growth, tax cuts provide earnings and dividend stability, and high short interest could result in a share squeeze.
03/21/18
UBSW
03/21/18
INITIATION
UBSW
Sell
New York Community Bancorp initiated with a Sell at UBS
03/22/18
UBSW
03/22/18
INITIATION
Target $12
UBSW
Sell
New York Community Bancorp initiated with a Sell at UBS
UBS analyst Brock Vandervliet started New York Community Bancorp with a Sell rating and $12 price target. The analyst rolled out coverage last night on the Mid-Cap Banks. He sees performance differentiation "playing out more starkly" than investors may expect with "increasingly advantaged and disadvantaged participants."
NLSN Nielsen
$30.73

0.215 (0.70%)

04/16/18
BMOC
04/16/18
UPGRADE
Target $38
BMOC
Outperform
Nielsen upgraded to Outperform at BMO Capital on Watch opportunity and valuation
As reported earlier, BMO Capital analyst Daniel Salmon upgraded Nielsen to Outperform from Market Perform and kept his $38 price target. Salmon says the heightened regulation on open internet platforms is a positive for a company involved with measurement and verification of data, which could increase demand for its products. The analyst also cites "excellent" innovation around the Watch side of its business discrediting investor view of its offerings becoming obsolete in a more digital world. Salmon further notes an attractive valuation for Nielsen as its stock trades at the trough multiple since its IPO.
04/16/18
BMOC
04/16/18
UPGRADE
BMOC
Outperform
Nielsen upgraded to Outperform from Market Perform at BMO Capital
04/16/18
04/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Costco (COST) upgraded to Outperform from Market Perform at Wells Fargo with analyst Edward Kelly saying he expects Costco to "sustain strong comp momentum" despite difficult comparisons, deliver improved membership trends, navigate rising retail cost pressures, and beat consensus expectations. 2. Boston Beer (SAM) upgraded to Neutral from Sell at Goldman Sachs. 3. Ulta Beauty (ULTA) upgraded to Buy from Neutral at Guggenheim with analyst Steven Forbes saying he believes Ulta's industry-leading position and secular growth potential is undervalued with shares trading at 10x 2019 EBITDA. 4. Nielsen (NLSN) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying the heightened regulation on open internet platforms is a positive for a company involved with measurement and verification of data, which could increase demand for its products. 5. C.H. Robinson (CHRW) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying trends in the first quarter are very favorable, which points to strong Q1 results for the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
BARD
01/08/18
UPGRADE
Target $41
BARD
Outperform
Nielsen upgraded to Outperform at Baird
As previously reported, Baird analyst Jeffrey Meuler upgraded Nielsen to Outperform from Neutral citing its depressed valuation and expectations for improved investors sentiment over time. The analyst sees signs of stabilization in its Buy-Developed Markets, sustained solid growth in Watch, and increased investor confidence in margin expansion. Meuler reiterated his $41 price target on Nielsen shares.
DFS Discover
$76.31

0.85 (1.13%)

05/07/18
UBSW
05/07/18
UPGRADE
UBSW
Neutral
Discover upgraded to Neutral from Sell at UBS
05/07/18
UBSW
05/07/18
UPGRADE
Target $72
UBSW
Neutral
Discover upgraded to Neutral at UBS
As previously reported, UBS analyst Eric Wasserstrom upgraded Discover to Neutral from Sell. He expects provision expense growth to remain elevated, though the earnings impact is mitigated by stronger interchange revenues than he had previously forecasted, said Wasserstrom, who raised his price target to $72 from $70 on Discover shares.
04/09/18
04/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he sees room for positive earnings revisions for GM, Ford (F) and Fiat Chrysler (FCAU) as investors better understand the impact on U.S. pick-up truck sales from a potential passage of a U.S. infrastructure bill. 2. TD Ameritrade (AMTD) upgraded to Buy from Neutral at BofA/Merrill with analyst Michael Carrier saying he views TD Ameritrade's near-term outlook as attractive given healthy new net asset growth, higher interest rates, and strong DARTs. 3. Comerica (CMA) upgraded to Outperform from Neutral at Wedbush with analyst Peter Winter saying he sees several levers that should drive above average earnings per share growth over the next two years, including margin expansion, potential resumption of loan growth, and above average capital returns. 4. Agilent (A) upgraded to Buy from Neutral at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools. 5. Discover (DFS) and Ally Financial (ALLY) were upgraded to Equal Weight from Underweight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/07/18
05/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) and AutoZone (AZO) were upgraded to Conviction Buy from Buy at Goldman Sachs. 2. Eaton (ETN), Deere (DE), and Terex (TEX) were upgraded to Outperform from In Line at Evercore ISI. 3. LendingTree (TREE) and Santander Consumer (SC) were upgraded to Buy from Neutral at UBS, while Discover (DFS) was upgraded to Neutral from Sell. 4. First Industrial Realty (FR) upgraded to Buy from Neutral at Mizuho with analyst Richard Anderson saying he sees a "path for outperformance from here" with the valuation at "floor" levels. 5. Illumina (ILMN) upgraded to Overweight from Equal Weight at Barclays with analyst Jack Meehan saying he believes his firm's NovaSeq customer survey indicates "substantial elasticity of demand." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

IGT

International Game

$28.47

-1.28 (-4.30%)

08:56
05/23/18
05/23
08:56
05/23/18
08:56
Syndicate
International Game 18M share Secondary priced at $28.25 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 23

    May

TSC

TriState Capital

$27.05

0.2 (0.74%)

08:56
05/23/18
05/23
08:56
05/23/18
08:56
Syndicate
TriState Capital 2.2M share Spot Secondary priced at $25.90 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 23

    May

TJX

TJX

$87.50

2.84 (3.35%)

, M

Macy's

$33.12

-1.48 (-4.28%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Recommendations
TJX, Macy's, Kohl's, J.C. Penney analyst commentary  »

TJX results 'more…

TJX

TJX

$87.50

2.84 (3.35%)

M

Macy's

$33.12

-1.48 (-4.28%)

KSS

Kohl's

$60.60

-4.87 (-7.44%)

JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MU

Micron

$58.95

3.47 (6.25%)

, BAC

Bank of America

$30.89

0.34 (1.11%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Options
Notable open interest changes for May 23rd »

Tuesday's total…

MU

Micron

$58.95

3.47 (6.25%)

BAC

Bank of America

$30.89

0.34 (1.11%)

NXPI

NXP Semiconductors

$115.55

0.84 (0.73%)

CHK

Chesapeake

$4.54

-0.065 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

SLB

Schlumberger

$73.74

-1.28 (-1.71%)

, EOG

EOG Resources

$123.76

-3.69 (-2.90%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Conference/Events
UBS to hold a conference »

Global Oil & Gas…

SLB

Schlumberger

$73.74

-1.28 (-1.71%)

EOG

EOG Resources

$123.76

-3.69 (-2.90%)

HP

Helmerich & Payne

$70.74

-1.83 (-2.52%)

RRC

Range Resources

$15.45

-0.63 (-3.92%)

SWN

Southwestern Energy

$4.66

-0.07 (-1.48%)

TDW

Tidewater

$31.48

0.1 (0.32%)

NE

Noble Corp.

$5.86

-0.15 (-2.50%)

HES

Hess Corp.

$63.83

-1.42 (-2.18%)

TUSK

Mammoth Energy

$34.59

-1.27 (-3.54%)

DVN

Devon Energy

$41.82

-0.51 (-1.20%)

ICD

Independence Contract Drilling

$4.89

-0.25 (-4.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

  • 25

    Jun

  • 27

    Jun

  • 20

    Jul

  • 19

    Aug

TMO

Thermo Fisher

$217.88

1.2 (0.55%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Conference/Events
Thermo Fisher to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

CY

Cypress Semiconductor

$16.31

0.2 (1.24%)

08:54
05/23/18
05/23
08:54
05/23/18
08:54
Initiation
Cypress Semiconductor initiated  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 13

    Jun

  • 14

    Jun

TOL

Toll Brothers

$39.46

-4.14 (-9.50%)

08:52
05/23/18
05/23
08:52
05/23/18
08:52
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$21.92

0.5 (2.33%)

08:51
05/23/18
05/23
08:51
05/23/18
08:51
Recommendations
Marvell analyst commentary  »

Marvell April quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IDTI

Integrated Device

$32.49

0.41 (1.28%)

08:50
05/23/18
05/23
08:50
05/23/18
08:50
Initiation
Integrated Device initiated  »

Integrated Device…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TIF

Tiffany

$102.26

-0.96 (-0.93%)

08:49
05/23/18
05/23
08:49
05/23/18
08:49
Hot Stocks
Tiffany says it had success in Japan, Europe »

Says sales rose 18% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

AOBC

American Outdoor Brands

$11.75

0.075 (0.64%)

, RGR

Sturm, Ruger

$60.90

0.6 (1.00%)

08:47
05/23/18
05/23
08:47
05/23/18
08:47
Periodicals
Trump admin to publish proposed rule changes for gun exports, Reuters reports »

The Trump administration…

AOBC

American Outdoor Brands

$11.75

0.075 (0.64%)

RGR

Sturm, Ruger

$60.90

0.6 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$127.87

-0.18 (-0.14%)

08:46
05/23/18
05/23
08:46
05/23/18
08:46
Hot Stocks
Pratt & Whitney announces up to $100M investment in West Palm Beach facility »

Pratt & Whitney, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

KSS

Kohl's

$60.60

-4.87 (-7.44%)

08:46
05/23/18
05/23
08:46
05/23/18
08:46
Recommendations
Kohl's analyst commentary  »

Morgan Stanley says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$39.68

1.78 (4.70%)

08:45
05/23/18
05/23
08:45
05/23/18
08:45
Hot Stocks
Breaking Hot Stocks news story on Esperion 

Esperion trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

DDAIF

Daimler AG

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

08:45
05/23/18
05/23
08:45
05/23/18
08:45
Periodicals
Model 3 sales beat BMW 3-Series, Mercedes C-Class in California, Electrek says »

Tesla's (TSLA) Model…

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

TSLA

Tesla

$275.01

-9.48 (-3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$22.30

-0.25 (-1.11%)

, S

Sprint

$5.18

0.01 (0.19%)

08:45
05/23/18
05/23
08:45
05/23/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

MDR

McDermott

$22.30

-0.25 (-1.11%)

S

Sprint

$5.18

0.01 (0.19%)

BZUN

Baozun

$53.13

0.44 (0.84%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.56

0.035 (0.04%)

IQ

iQIYI

$22.51

2.27 (11.22%)

XLU

Utilities SPDR

$49.44

0.2 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LOW

Lowe's

$85.74

-1.63 (-1.87%)

08:44
05/23/18
05/23
08:44
05/23/18
08:44
Technical Analysis
Technical Take: Lowe's rises after earnings and outlook »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

, SPX

S&P 500

$0.00

(0.00%)

08:43
05/23/18
05/23
08:43
05/23/18
08:43
General news
Trump says China trade deal 'moving along nicely,' may need different structure »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$125.00

0.05 (0.04%)

08:43
05/23/18
05/23
08:43
05/23/18
08:43
Conference/Events
International Flavors management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

WPP

WPP

$91.49

0.62 (0.68%)

, HSBC

HSBC

$50.54

0.575 (1.15%)

08:41
05/23/18
05/23
08:41
05/23/18
08:41
Periodicals
WPP diivision loses HSBC account, FT reports »

WPP (WPP) has lost HSBC…

WPP

WPP

$91.49

0.62 (0.68%)

HSBC

HSBC

$50.54

0.575 (1.15%)

OMC

Omnicom

$75.27

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTO

Vista Outdoor

$14.08

0.16 (1.15%)

08:41
05/23/18
05/23
08:41
05/23/18
08:41
Conference/Events
Vista Outdoor management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

TGT

Target

$75.42

-1.44 (-1.87%)

08:41
05/23/18
05/23
08:41
05/23/18
08:41
Hot Stocks
Target sees ROIC growing into mid-teens over long-term »

Sees FY CapEx $3.5B. Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

VTGN

VistaGen Therapeutics

$0.99

-0.01 (-1.00%)

08:40
05/23/18
05/23
08:40
05/23/18
08:40
Hot Stocks
VistaGen Therapeutics granted U.S. patent for osteoarthritis and joint injuries »

VistaGen Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINC

Premier

$32.35

0.16 (0.50%)

08:38
05/23/18
05/23
08:38
05/23/18
08:38
Conference/Events
Premier management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.